慢性静脈閉塞症治療の世界市場レポート 2025年

慢性静脈閉塞症治療市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR6.7％で93億2,000万米ドルに成長します。予測期間の成長は、静脈疾患に対する意識の高まり、低侵襲手術に対する需要の高まり、人口の高齢化、血管内治療の進歩、患者中心のケアへの注力などに起因すると考えられます。予測期間における主な動向としては、低侵襲手技の進歩、インターベンショナル・ラジオロジーにおける技術革新、血管内治療への注力、静脈疾患の有病率の増加、高齢化人口の増加などが挙げられます。

予測される肥満症例の増加は、今後の慢性静脈閉塞症治療市場の成長を牽引するとみられます。肥満症は、体脂肪の過剰な蓄積によって体格指数（BMI）が30以上になることを特徴とし、浮腫や皮膚の変化などの症状を伴うことがあります。慢性静脈閉塞症治療は、血流を改善し、炎症を抑えることにより、これらの症状を管理し、効果的な肥満管理に貢献するという重要な役割を担っています。世界心臓連盟が2023年3月に報告したように、全世界で約23億人の成人および小児が肥満または過体重です。現在の肥満動向では、2025年までに肥満の人の数は27億人に達すると予測されています。したがって、肥満の有病率の増加が慢性静脈閉塞症治療市場の成長を促進する重要な要因となっています。

低侵襲手技の採用拡大が慢性静脈閉塞症治療市場の成長を牽引するとみられます。低侵襲処置は、大きな外科的切開とは対照的に、小さな切開または自然な体の開口部を通して行われる医療および外科技術を含みます。これらの手技は、感染症、出血、瘢痕化などの合併症のリスクを低くすることにつながります。慢性静脈閉塞症の患者にはさらに健康上の懸念があることが多いため、合併症のリスクを最小限に抑えることは患者全体の健康にとって不可欠です。例えば、2024年6月、英国を拠点とする認定形成外科医のための専門組織である国際美容形成外科学会（ISAPS）は、2023年、外科手術と非外科手術の総数が3.4％増加し、3,490万件に達したと報告しました。脂肪吸引術は、豊胸術を上回り、女性の間で最も人気のある手術法として浮上し、180万件の手術が行われ、2021年から29％増加しました。そのため、低侵襲手術の採用が増加しており、慢性静脈閉塞症治療市場の成長に拍車をかけています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、コロナ、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界慢性静脈閉塞症治療PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の慢性静脈閉塞症治療市場：成長率分析
• 世界の慢性静脈閉塞症治療市場の実績：規模と成長, 2019-2024
• 世界の慢性静脈閉塞症治療市場の予測：規模と成長, 2024-2029, 2034F
• 世界慢性静脈閉塞症治療総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の慢性静脈閉塞症治療市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• デバイス
• 薬物
• 世界の慢性静脈閉塞症治療市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 静脈瘤
• 静脈うっ滞性潰瘍
• 浮腫
• 深部静脈血栓症
• その他の用途
• 世界の慢性静脈閉塞症治療市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• クリニック
• 外来手術センター
• 外傷センター
• その他のエンドユーザー
• 世界の慢性静脈閉塞症治療市場、デバイスの種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 静脈ステント
• カテーテル
• 静脈内レーザー治療（EVLT）装置
• 血管形成術用バルーン
• その他の介入装置
• 世界の慢性静脈閉塞症治療市場、薬物の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 抗凝固剤
• 血栓溶解剤
• 抗炎症薬
• 疼痛管理薬
• その他の薬物療法

第7章 地域別・国別分析

• 世界の慢性静脈閉塞症治療市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の慢性静脈閉塞症治療市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 慢性静脈閉塞症治療市場：競合情勢
• 慢性静脈閉塞症治療市場：企業プロファイル
  • Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 3M Company Overview, Products and Services, Strategy and Financial Analysis
  • Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Medtronic PLC
• Becton, Dickinson and Company（BD）
• Stryker Corporation
• Boston Scientific Corporation
• Terumo Corporation
• Ethicon Inc.
• Philips Medical Systems
• Teleflex Incorporated
• Cook Group Incorporated
• Merit Medical Systems Inc.
• Integer Holdings Corporation
• Penumbra Inc.
• Inari Medical
• Argon Medical Devices Inc.
• AngioDynamics Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 慢性静脈閉塞症治療市場2029：新たな機会を提供する国
• 慢性静脈閉塞症治療市場2029：新たな機会を提供するセグメント
• 慢性静脈閉塞症治療市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Chronic venous occlusion refers to the prolonged blockage or obstruction of veins, commonly occurring in the legs or arms, which can hinder blood flow and result in various health issues such as swelling, pain, and skin changes. Treatment aims to alleviate symptoms, slow down the disease's progression, and prevent complications.

The primary categories of products within chronic venous occlusion treatment include devices and drugs. Devices encompass instruments, apparatuses, machines, or implants utilized for prevention, diagnosis, or treatment. In chronic venous occlusion treatment, devices play a crucial role in restoring proper blood flow and enhancing overall venous health, contributing to the success of treatment outcomes. These applications span various conditions, including varicose veins, venous stasis ulcers, edema, deep vein thrombosis, and others. They are utilized by hospitals, clinics, ambulatory surgery centers, trauma centers, and other healthcare facilities.

The chronic venous occlusions treatment market research report is one of a series of new reports from The Business Research Company that provides chronic venous treatment market statistics, including chronic venous occlusions treatment industry global market size, regional shares, competitors with a chronic venous occlusions treatment market share, detailed chronic venous occlusions treatment market segments, market trends and opportunities, and any further data you may need to thrive in the chronic venous occlusions treatment industry. This chronic venous occlusions treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The chronic venous occlusions treatment market size has grown strongly in recent years. It will grow from $6.7 billion in 2024 to $7.19 billion in 2025 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to investments in treatment innovation, rise in venous disorder prevalence, awareness and diagnosis improvement, clinical trials and research initiatives, improved patient outcomes and quality of life.

The chronic venous occlusions treatment market size is expected to see strong growth in the next few years. It will grow to $9.32 billion in 2029 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to rise in venous disorders awareness, rising demand for minimally invasive procedures, ageing population dynamics, advancements in endovascular therapies, focus on patient-centric care. Major trends in the forecast period include advancements in minimally invasive procedures, technological innovations in interventional radiology, focus on endovascular therapies, growing prevalence of venous disorders, rise in aging population.

The anticipated rise in obesity cases is set to drive the growth of the chronic venous occlusion treatment market in the future. Obesity, characterized by an excessive accumulation of body fat leading to a body mass index (BMI) of 30 or higher, can be associated with symptoms such as edema and skin changes. Chronic venous occlusion treatment plays a crucial role in managing these symptoms by improving blood flow and reducing inflammation, contributing to effective obesity management. As reported in March 2023 by the World Heart Federation, around 2.3 billion adults and children globally were either obese or overweight. With the current obesity trend, it is projected that the number of individuals with obesity will reach 2.7 billion by 2025. Therefore, the increasing prevalence of obesity is a key factor propelling the growth of the chronic venous occlusion treatment market.

The growing adoption of minimally invasive procedures is expected to drive the growth of the chronic venous occlusions treatment market. Minimally invasive procedures involve medical and surgical techniques performed through small incisions or natural body openings, as opposed to large surgical cuts. These techniques are linked to a lower risk of complications such as infections, bleeding, and scarring. Since patients with chronic venous occlusions often have additional health concerns, minimizing the risk of complications is vital for their overall health. For example, in June 2024, the International Society of Aesthetic Plastic Surgery (ISAPS), a UK-based professional organization for certified plastic surgeons, reported that in 2023, the total number of both surgical and non-surgical procedures grew by 3.4%, reaching 34.9 million. Liposuction emerged as the most popular surgical procedure among women, surpassing breast augmentation, with 1.8 million procedures performed-a 29% increase since 2021. Therefore, the rising adoption of minimally invasive procedures is fueling the growth of the chronic venous occlusion treatment market.

Key players in the chronic venous occlusion treatment market are concentrating on developing innovative solutions, such as implantable medical devices designed to treat symptomatic venous outflow obstruction in patients with chronic venous insufficiency (CVI). An implantable medical device is a device surgically placed inside the body for long-term use, typically for diagnosing, treating, or monitoring medical conditions. For example, in June 2024, Koninklijke Philips N.V. (Philips), a technology company based in the Netherlands, launched the Duo Venous Stent System, an implantable medical device. The Duo Venous Stent System features a dual-layer design that enhances flexibility and radial strength for optimal vein support. Its advanced coating improves biocompatibility and reduces the risk of thrombosis, while the precise delivery system ensures accurate placement in challenging anatomical conditions.

In January 2022, Koninklijke Philips N.V. (Philips) acquired Vesper Medical, a biotechnology company based in Canada, for an undisclosed amount. This acquisition strengthens Philips' portfolio in vascular health solutions, enabling the development of advanced treatments for venous diseases. The move positions Philips to capitalize on innovative technologies, which could increase its market share and enhance patient outcomes in the expanding vascular intervention market. Vesper Medical specializes in the treatment of deep venous disease.

Major companies operating in the chronic venous occlusions treatment market report are Cardinal Health Inc., Bayer AG, Sanofi S.A., 3M Company, Bristol-Myers Squibb Company, Medtronic PLC, Becton, Dickinson and Company (BD), Stryker Corporation, Boston Scientific Corporation, Terumo Corporation, Ethicon Inc., Philips Medical Systems, Teleflex Incorporated, Cook Group Incorporated, Merit Medical Systems Inc., Integer Holdings Corporation, Penumbra Inc., Inari Medical, Argon Medical Devices Inc., AngioDynamics Inc., Rontis Corporation, Endologix, Richard Wolf GmbH, SIGVARIS AG, enVVeno Medical Corporation, LimFlow SA

North America was the largest region in the chronic venous occlusions treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chronic venous occlusions treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the chronic venous occlusions treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The chronic venous occlusion treatment market consists of revenues earned by entities by providing services such as magnetic resonance imaging (MRI), fluoroscopy, computerized tomography (CT) scanning, anticoagulation therapy, and surgical intervention. The market value includes the value of related goods sold by the service provider or included within the service offering. The chronic venous occlusion treatment market also includes sales of anticoagulants, thrombolytic agents, pain relievers, and anti-inflammatory drugs. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Chronic Venous Occlusions Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on chronic venous occlusions treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for chronic venous occlusions treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The chronic venous occlusions treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Devices; Drugs
• 2) By Application: Varicose Veins; Venous Stasis Ulcers; Edema; Deep Vein Thrombosis; Other Applications
• 3) By End User: Hospitals; Clinics; Ambulatory Surgery Centers; Trauma centers; Other End-Users
• Subsegments:
• 1) By Devices: Venous Stents; Catheters; Endovenous Laser Therapy (EVLT) Devices; Angioplasty Balloons; Other Interventional Devices
• 2) By Drugs: Anticoagulants; Thrombolytics; Anti-inflammatory Medications; Pain Management Drugs; Other Pharmacological Treatments
• Companies Mentioned: Cardinal Health Inc.; Bayer AG; Sanofi S.A.; 3M Company; Bristol-Myers Squibb Company
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Chronic Venous Occlusions Treatment Market Characteristics

3. Chronic Venous Occlusions Treatment Market Trends And Strategies

4. Chronic Venous Occlusions Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Chronic Venous Occlusions Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Chronic Venous Occlusions Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Chronic Venous Occlusions Treatment Market Growth Rate Analysis
• 5.4. Global Chronic Venous Occlusions Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Chronic Venous Occlusions Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Chronic Venous Occlusions Treatment Total Addressable Market (TAM)

6. Chronic Venous Occlusions Treatment Market Segmentation

• 6.1. Global Chronic Venous Occlusions Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Devices
• Drugs
• 6.2. Global Chronic Venous Occlusions Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Varicose Veins
• Venous Stasis Ulcers
• Edema
• Deep Vein Thrombosis
• Other Applications
• 6.3. Global Chronic Venous Occlusions Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Ambulatory Surgery Centers
• Trauma centers
• Other End-Users
• 6.4. Global Chronic Venous Occlusions Treatment Market, Sub-Segmentation Of Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Venous Stents
• Catheters
• Endovenous Laser Therapy (EVLT) Devices
• Angioplasty Balloons
• Other Interventional Devices
• 6.5. Global Chronic Venous Occlusions Treatment Market, Sub-Segmentation Of Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Anticoagulants
• Thrombolytics
• Anti-inflammatory Medications
• Pain Management Drugs
• Other Pharmacological Treatments

7. Chronic Venous Occlusions Treatment Market Regional And Country Analysis

• 7.1. Global Chronic Venous Occlusions Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Chronic Venous Occlusions Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Chronic Venous Occlusions Treatment Market

• 8.1. Asia-Pacific Chronic Venous Occlusions Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Chronic Venous Occlusions Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Chronic Venous Occlusions Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Chronic Venous Occlusions Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Chronic Venous Occlusions Treatment Market

• 9.1. China Chronic Venous Occlusions Treatment Market Overview
• 9.2. China Chronic Venous Occlusions Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Chronic Venous Occlusions Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Chronic Venous Occlusions Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Chronic Venous Occlusions Treatment Market

• 10.1. India Chronic Venous Occlusions Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Chronic Venous Occlusions Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Chronic Venous Occlusions Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Chronic Venous Occlusions Treatment Market

• 11.1. Japan Chronic Venous Occlusions Treatment Market Overview
• 11.2. Japan Chronic Venous Occlusions Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Chronic Venous Occlusions Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Chronic Venous Occlusions Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Chronic Venous Occlusions Treatment Market

• 12.1. Australia Chronic Venous Occlusions Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Chronic Venous Occlusions Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Chronic Venous Occlusions Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Chronic Venous Occlusions Treatment Market

• 13.1. Indonesia Chronic Venous Occlusions Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Chronic Venous Occlusions Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Chronic Venous Occlusions Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Chronic Venous Occlusions Treatment Market

• 14.1. South Korea Chronic Venous Occlusions Treatment Market Overview
• 14.2. South Korea Chronic Venous Occlusions Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Chronic Venous Occlusions Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Chronic Venous Occlusions Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Chronic Venous Occlusions Treatment Market

• 15.1. Western Europe Chronic Venous Occlusions Treatment Market Overview
• 15.2. Western Europe Chronic Venous Occlusions Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Chronic Venous Occlusions Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Chronic Venous Occlusions Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Chronic Venous Occlusions Treatment Market

• 16.1. UK Chronic Venous Occlusions Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Chronic Venous Occlusions Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Chronic Venous Occlusions Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Chronic Venous Occlusions Treatment Market

• 17.1. Germany Chronic Venous Occlusions Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Chronic Venous Occlusions Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Chronic Venous Occlusions Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Chronic Venous Occlusions Treatment Market

• 18.1. France Chronic Venous Occlusions Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Chronic Venous Occlusions Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Chronic Venous Occlusions Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Chronic Venous Occlusions Treatment Market

• 19.1. Italy Chronic Venous Occlusions Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Chronic Venous Occlusions Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Chronic Venous Occlusions Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Chronic Venous Occlusions Treatment Market

• 20.1. Spain Chronic Venous Occlusions Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Chronic Venous Occlusions Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Chronic Venous Occlusions Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Chronic Venous Occlusions Treatment Market

• 21.1. Eastern Europe Chronic Venous Occlusions Treatment Market Overview
• 21.2. Eastern Europe Chronic Venous Occlusions Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Chronic Venous Occlusions Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Chronic Venous Occlusions Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Chronic Venous Occlusions Treatment Market

• 22.1. Russia Chronic Venous Occlusions Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Chronic Venous Occlusions Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Chronic Venous Occlusions Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Chronic Venous Occlusions Treatment Market

• 23.1. North America Chronic Venous Occlusions Treatment Market Overview
• 23.2. North America Chronic Venous Occlusions Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Chronic Venous Occlusions Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Chronic Venous Occlusions Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Chronic Venous Occlusions Treatment Market

• 24.1. USA Chronic Venous Occlusions Treatment Market Overview
• 24.2. USA Chronic Venous Occlusions Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Chronic Venous Occlusions Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Chronic Venous Occlusions Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Chronic Venous Occlusions Treatment Market

• 25.1. Canada Chronic Venous Occlusions Treatment Market Overview
• 25.2. Canada Chronic Venous Occlusions Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Chronic Venous Occlusions Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Chronic Venous Occlusions Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Chronic Venous Occlusions Treatment Market

• 26.1. South America Chronic Venous Occlusions Treatment Market Overview
• 26.2. South America Chronic Venous Occlusions Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Chronic Venous Occlusions Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Chronic Venous Occlusions Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Chronic Venous Occlusions Treatment Market

• 27.1. Brazil Chronic Venous Occlusions Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Chronic Venous Occlusions Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Chronic Venous Occlusions Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Chronic Venous Occlusions Treatment Market

• 28.1. Middle East Chronic Venous Occlusions Treatment Market Overview
• 28.2. Middle East Chronic Venous Occlusions Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Chronic Venous Occlusions Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Chronic Venous Occlusions Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Chronic Venous Occlusions Treatment Market

• 29.1. Africa Chronic Venous Occlusions Treatment Market Overview
• 29.2. Africa Chronic Venous Occlusions Treatment Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Chronic Venous Occlusions Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Chronic Venous Occlusions Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Chronic Venous Occlusions Treatment Market Competitive Landscape And Company Profiles

• 30.1. Chronic Venous Occlusions Treatment Market Competitive Landscape
• 30.2. Chronic Venous Occlusions Treatment Market Company Profiles
  • 30.2.1. Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. 3M Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

31. Chronic Venous Occlusions Treatment Market Other Major And Innovative Companies

• 31.1. Medtronic PLC
• 31.2. Becton, Dickinson and Company (BD)
• 31.3. Stryker Corporation
• 31.4. Boston Scientific Corporation
• 31.5. Terumo Corporation
• 31.6. Ethicon Inc.
• 31.7. Philips Medical Systems
• 31.8. Teleflex Incorporated
• 31.9. Cook Group Incorporated
• 31.10. Merit Medical Systems Inc.
• 31.11. Integer Holdings Corporation
• 31.12. Penumbra Inc.
• 31.13. Inari Medical
• 31.14. Argon Medical Devices Inc.
• 31.15. AngioDynamics Inc.

32. Global Chronic Venous Occlusions Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Chronic Venous Occlusions Treatment Market

34. Recent Developments In The Chronic Venous Occlusions Treatment Market

35. Chronic Venous Occlusions Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Chronic Venous Occlusions Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Chronic Venous Occlusions Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Chronic Venous Occlusions Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer